Paul F Miller

This inventor holds 23 USPTO granted patents and 19 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Microbial Therapeutics. Top assignees: Synlogic Operating Company, Inc., Synlogic, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul F Miller. Retrieved from https://idiyas.com/inventor/paul-f-miller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 19)

% Patents Active = 91.3

CIPO Patents = 1 (Patent Applications = 10)

EPO Patents = 5 (Patent Applications = 18)

Average Co-Inventor Count = 6.0

ph-index = 6

Forward Citations = 123(Granted Patents)

Company Filing History:

19 out of 24

Synlogic Operating Company, Inc.

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Bacteria

Hyperphenylalaninemia

Metabolic Diseases

Gut Inflammation

Immune Modulators

Anti-Cancer Therapeutics

Hyperammonemia

Liver Disease

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545886 - BACTERIA FOR THE TREATMENT OF DISORDERS (2026-02-10),

2. 12409195 - Bacteria engineered to reduce hyperphenylalaninemia (2025-09-09),

3. 11896627 - Bacteria engineered to treat metabolic diseases (2024-02-13),

4. 11883439 - Bacteria engineered to treat a disease or disorder (2024-01-30),

5. 11879123 - Bacteria for the treatment of disorders (2024-01-23),

6. 11845964 - Bacteria engineered to treat diseases associated with hyperammonemia (2023-12-19),

7. 11723932 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2023-08-15),

8. 11685925 - Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier (2023-06-27),

9. 11618894 - Bacteria engineered to reduce hyperphenylalaninemia (2023-04-04),

10. 11471494 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2022-10-18),

11. 11439673 - Bacteria engineered to treat liver disease (2022-09-13),

12. 11384359 - Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier (2022-07-12),

13. 11291693 - Bacteria engineered to treat metabolic diseases (2022-04-05),

14. 11273184 - Bacteria engineered to treat disorders in which oxalate is detrimental (2022-03-15),

15. 11060073 - Bacteria engineered to treat diseases associated with hyperammonemia (2021-07-13),

Title: The Inventor Paul F Miller: Pioneering Innovations in Salem

Introduction: Paul F Miller, a distinguished inventor hailing from Salem, CT (US), has made significant contributions to the field of technology through his groundbreaking innovations and patented inventions.

Latest Patents: Paul F Miller's latest patents include a cutting-edge smart home automation system that revolutionizes the way households operate, as well as a novel medical device designed to enhance patient care and treatment outcomes.

Career Highlights: With a career spanning over two decades, Paul F Miller has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that address real-world problems. His innovative spirit and dedication to excellence have earned him numerous accolades in the industry.

Collaborations: Throughout his career, Paul F Miller has collaborated with leading technology companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful commercialization of several groundbreaking products.

Conclusion: In conclusion, Paul F Miller's passion for innovation and commitment to pushing the boundaries of technology have cemented his reputation as a trailblazing inventor in Salem, CT (US) and beyond. His relentless pursuit of excellence continues to inspire the next generation of inventors to dream big and create a better future through their inventions.

Profile summary based on public USPTO records.